Halldin C - Search Results

1

Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline.

Sturm S, Forsberg A, Nave S, Stenkrona P, Seneca N, Varrone A, Comley RA, Fazio P, Jamois C, Nakao R, Ejduk Z, Al-Tawil N, Akenine U, Halldin C, Andreasen N, Ricci B. Sturm S, et al. Among authors: halldin c. Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):382-391. doi: 10.1007/s00259-016-3510-6. Epub 2016 Sep 16. Eur J Nucl Med Mol Imaging. 2017. PMID: 27633250 Free PMC article. Clinical Trial.

2

Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.

Blomqvist G, Pauli S, Farde L, Eriksson L, Persson A, Halldin C. Blomqvist G, et al. Among authors: halldin c. Eur J Nucl Med. 1990;16(4-6):257-65. doi: 10.1007/BF00842777. Eur J Nucl Med. 1990. PMID: 2112470

3

The Bücherer-Strecker synthesis of D- and L-(1-11C)tyrosine and the in vivo study of L-(1-11C)tyrosine in human brain using positron emission tomography.

Halldin C, Schoeps KO, Stone-Elander S, Wiesel FA. Halldin C, et al. Eur J Nucl Med. 1987;13(6):288-91. doi: 10.1007/BF00256552. Eur J Nucl Med. 1987. PMID: 3499325

4

Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patients.

Farde L, Nyberg S, Oxenstierna G, Nakashima Y, Halldin C, Ericsson B. Farde L, et al. Among authors: halldin c. J Clin Psychopharmacol. 1995 Feb;15(1 Suppl 1):19S-23S. doi: 10.1097/00004714-199502001-00004. J Clin Psychopharmacol. 1995. PMID: 7537284

5

Positron emission tomography shows high specific uptake of racemic carbon-11 labelled norepinephrine in the primate heart.

Farde L, Halldin C, Någren K, Suhara T, Karlsson P, Schoeps KO, Swahn CG, Bone D. Farde L, et al. Among authors: halldin c. Eur J Nucl Med. 1994 Apr;21(4):345-7. doi: 10.1007/BF00947971. Eur J Nucl Med. 1994. PMID: 8005159

6

Preparation of a potential positron emission tomographic radioligand for the dopamine transporter.

Müller L, Halldin C, Foged C, Karlsson P, Hall H, Swahn CG, Suzdak PD, Hohlweg R, Nielsen EB, Farde L. Müller L, et al. Among authors: halldin c. Eur J Nucl Med. 1994 Feb;21(2):131-7. doi: 10.1007/BF00175760. Eur J Nucl Med. 1994. PMID: 8162936

7

[O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations.

Lundkvist C, Halldin C, Swahn CG, Hall H, Karlsson P, Nakashima Y, Wang S, Milius RA, Neumeyer JL, Farde L. Lundkvist C, et al. Among authors: halldin c. Nucl Med Biol. 1995 Oct;22(7):905-13. doi: 10.1016/0969-8051(95)00029-w. Nucl Med Biol. 1995. PMID: 8547888

8

Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man.

Nyberg S, Nordström AL, Halldin C, Farde L. Nyberg S, et al. Among authors: halldin c. Int Clin Psychopharmacol. 1995 Sep;10 Suppl 3:81-5. Int Clin Psychopharmacol. 1995. PMID: 8866769

9

In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.

Bergström KA, Halldin C, Hall H, Lundkvist C, Ginovart N, Swahn CG, Farde L. Bergström KA, et al. Among authors: halldin c. Eur J Nucl Med. 1997 Jun;24(6):596-601. doi: 10.1007/BF00841395. Eur J Nucl Med. 1997. PMID: 9169564

10

Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.

Halldin C, Högberg T, Farde L. Halldin C, et al. Nucl Med Biol. 1994 May;21(4):627-31. doi: 10.1016/0969-8051(94)90028-0. Nucl Med Biol. 1994. PMID: 9234320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

683 results

Search Page

Filters